Clinical Trial Update: A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing the safety of the faricimab prefilled syringe in patients with neovascular age-related macular degeneration or diabetic macular e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2023-10-10